HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Sato Selected Research

KF38789

11/2001Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Sato Research Topics

Disease

54Neoplasms (Cancer)
01/2021 - 01/2000
49Systemic Scleroderma (Systemic Sclerosis)
02/2021 - 01/2000
24Inflammation (Inflammations)
04/2019 - 01/2000
17Fibrosis (Cirrhosis)
07/2020 - 01/2000
17Infections
12/2015 - 01/2000
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2018 - 01/2000
14Carcinoma (Carcinomatosis)
01/2008 - 01/2000
13Psoriasis (Pustulosis Palmaris et Plantaris)
03/2016 - 12/2000
13Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2015 - 01/2000
11Ovarian Neoplasms (Ovarian Cancer)
09/2001 - 01/2000
8Localized Scleroderma (Morphea)
07/2020 - 08/2000
8Autoimmune Diseases (Autoimmune Disease)
04/2020 - 03/2001
8Neoplasm Metastasis (Metastasis)
07/2018 - 01/2000
8Rheumatoid Arthritis
01/2018 - 01/2001
8Dermatomyositis (Dermatopolymyositis)
02/2010 - 01/2000
8Ovarian Epithelial Carcinoma
05/2008 - 01/2000
7Necrosis
03/2022 - 02/2006
7Sclerosis
02/2021 - 01/2000
7Interstitial Lung Diseases (Interstitial Lung Disease)
04/2020 - 09/2005
7Hepatocellular Carcinoma (Hepatoma)
10/2013 - 03/2000
7Atopic Dermatitis (Atopic Eczema)
01/2013 - 07/2001
7Adenocarcinoma
09/2007 - 01/2000
6Body Weight (Weight, Body)
08/2013 - 01/2001
6Multiple Sclerosis
07/2010 - 12/2002
6Coronary Disease (Coronary Heart Disease)
04/2009 - 09/2000
6Myositis (Idiopathic Inflammatory Myopathies)
01/2009 - 01/2000
6Endometrial Neoplasms (Endometrial Cancer)
07/2001 - 03/2000
6Urinary Tract Infections (Urinary Tract Infection)
06/2001 - 04/2000
5Colonic Neoplasms (Colon Cancer)
01/2021 - 11/2000
5Cicatrix (Scar)
02/2018 - 02/2000
5Disease Progression
12/2016 - 07/2001
5Hemorrhage
03/2016 - 01/2000
5Hypoxia (Hypoxemia)
03/2016 - 09/2000
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2013 - 01/2000
5Neuromyelitis Optica (Devic's Disease)
07/2010 - 09/2006
5Stomach Neoplasms (Stomach Cancer)
01/2003 - 01/2000
5Pancreatitis
09/2001 - 01/2000
4Thrombosis (Thrombus)
03/2022 - 12/2000
4Ulcer
12/2018 - 01/2000
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 08/2000
4Asthma (Bronchial Asthma)
01/2018 - 10/2006
4Stroke (Strokes)
03/2016 - 03/2001
4Leukemia
11/2012 - 04/2000
4Hypertension (High Blood Pressure)
06/2011 - 09/2000
4Lung Neoplasms (Lung Cancer)
05/2011 - 09/2000
4Renal Cell Carcinoma (Grawitz Tumor)
09/2006 - 01/2001
4Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2003 - 01/2000
4Lymphatic Metastasis
01/2003 - 06/2000
4Endometrioid Carcinoma
01/2003 - 10/2000
4Sarcoidosis (Schaumann Disease)
06/2002 - 10/2000
4Unconsciousness (Loss of Consciousness)
02/2001 - 01/2000
3Polymyositis
04/2020 - 01/2007
3Lupus Nephritis
04/2019 - 07/2014
3Communicable Diseases (Infectious Diseases)
01/2018 - 12/2000
3Cardiovascular Diseases (Cardiovascular Disease)
04/2017 - 10/2005
3Insulin Resistance
04/2017 - 04/2012
3Chronic Periodontitis
01/2017 - 07/2012
3Skin Diseases (Skin Disease)
03/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
04/2020 - 04/2000
20AutoantibodiesIBA
04/2020 - 01/2000
17Immunoglobulin G (IgG)IBA
12/2016 - 08/2001
16AntibodiesIBA
01/2016 - 01/2000
14CytokinesIBA
01/2018 - 12/2000
14EnzymesIBA
01/2013 - 04/2000
10AntigensIBA
10/2009 - 01/2000
9Messenger RNA (mRNA)IBA
03/2022 - 01/2000
9ImmunosorbentsIBA
01/2013 - 08/2003
8anti-scl-70 autoantibodiesIBA
12/2009 - 04/2001
8Cisplatin (Platino)FDA LinkGeneric
09/2007 - 01/2000
7Biomarkers (Surrogate Marker)IBA
02/2021 - 04/2004
7Propofol (Diprivan)FDA LinkGeneric
07/2013 - 04/2000
7Indicators and Reagents (Reagents)IBA
04/2012 - 01/2000
6Pharmaceutical PreparationsIBA
01/2017 - 05/2001
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 06/2000
6CollagenIBA
11/2012 - 01/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006 - 01/2000
6Anti-Infective Agents (Microbicides)IBA
06/2001 - 04/2000
5Glucose (Dextrose)FDA LinkGeneric
04/2017 - 08/2000
5ChemokinesIBA
10/2014 - 06/2001
5DNA (Deoxyribonucleic Acid)IBA
07/2014 - 01/2000
5Interleukin-6 (Interleukin 6)IBA
04/2012 - 08/2000
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2009 - 01/2000
5Peptides (Polypeptides)IBA
01/2009 - 01/2000
5L-SelectinIBA
02/2006 - 07/2000
4Oxygen (Dioxygen)IBA
03/2016 - 11/2001
4SteroidsIBA
02/2009 - 12/2000
4RNA (Ribonucleic Acid)IBA
10/2008 - 11/2000
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2006 - 07/2000
4InterferonsIBA
02/2006 - 05/2001
3Prednisolone (Predate)FDA LinkGeneric
07/2018 - 01/2000
3Immunosuppressive Agents (Immunosuppressants)IBA
01/2017 - 01/2001
3Rituximab (Mabthera)FDA Link
01/2017 - 12/2015

Therapy/Procedure

23Therapeutics
04/2019 - 01/2000
20Drug Therapy (Chemotherapy)
07/2020 - 01/2000
7Radiotherapy
11/2006 - 01/2000
4Lymph Node Excision (Lymph Node Dissection)
01/2021 - 03/2000
4Aftercare (After-Treatment)
01/2017 - 04/2000
4Immunotherapy
01/2008 - 03/2001
4Hysterectomy
09/2000 - 01/2000
4Gastrectomy
01/2000 - 01/2000